Latest news
SYNC-T Therapy SV-102 Shows Early Promise, Advances to Phase 2 LEGION-100 Trial in Refractory Prostate Cancer - OncLiveOncLive · Mon, 10 Aug 2026 12:11:30 GMTElicio Study to Test Immunotherapy Before Pancreatic Cancer Surgery - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:00 GMTClene ALS Trial Links Nerve-Injury Marker to Nearly 6-Month Survival Gain - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:00 GMTCan Mini Organs Help Predict Breast Tumors’ Response to Therapy? | Newswise - NewswiseNewswise · Mon, 10 Aug 2026 11:45:00 GMTHeart failure drug from Tenax Therapeutics fails in pivotal study - STATSTAT · Mon, 10 Aug 2026 11:43:53 GMTWHO calls for Phase III Ervebo vaccine trial amid Bundibugyo Ebola outbreak - Clinical Trials ArenaClinical Trials Arena · Mon, 10 Aug 2026 11:17:40 GMTSoligenix culls topical lymphoma asset after Phase III miss - Clinical Trials ArenaClinical Trials Arena · Mon, 10 Aug 2026 11:17:14 GMTAbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile - businesswire.combusinesswire.com · Mon, 10 Aug 2026 11:00:00 GMT